Clearline Capital LP Has Boosted Viacom New (VIAB) Position by $3.49 Million; Regeneron Pharmaceuticals (REGN) Holding Has Increased by Southpoint Capital Advisors Lp

April 19, 2018 - By Darrin Black

Viacom, Inc. (NASDAQ:VIAB) Logo

Rob Butts increased its stake in Regeneron Pharmaceuticals (REGN) by 57.14% based on its latest 2017Q4 regulatory filing with the SEC. Southpoint Capital Advisors Lp bought 40,000 shares as the company’s stock declined 13.59% with the market. The hedge fund run by Rob Butts held 110,000 shares of the health care company at the end of 2017Q4, valued at $41.36 million, up from 70,000 at the end of the previous reported quarter. Southpoint Capital Advisors Lp who had been investing in Regeneron Pharmaceuticals for a number of months, seems to be bullish on the $34.03 billion market cap company. The stock decreased 1.58% or $5.07 during the last trading session, reaching $316.32. About 386,492 shares traded. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has declined 14.19% since April 19, 2017 and is downtrending. It has underperformed by 25.74% the S&P500.

Marc Majzner increased its stake in Viacom Inc New (VIAB) by 32.57% based on its latest 2017Q4 regulatory filing with the SEC. Clearline Capital Lp bought 116,373 shares as the company’s stock declined 4.65% with the market. The hedge fund run by Marc Majzner held 473,686 shares of the television services company at the end of 2017Q4, valued at $14.59M, up from 357,313 at the end of the previous reported quarter. Clearline Capital Lp who had been investing in Viacom Inc New for a number of months, seems to be bullish on the $12.62B market cap company. The stock decreased 1.47% or $0.46 during the last trading session, reaching $30.8. About 2.05M shares traded. Viacom, Inc. (NASDAQ:VIAB) has declined 30.65% since April 19, 2017 and is downtrending. It has underperformed by 42.20% the S&P500.

Among 39 analysts covering Viacom Inc. (NASDAQ:VIAB), 13 have Buy rating, 0 Sell and 26 Hold. Therefore 33% are positive. Viacom Inc. had 135 analyst reports since August 7, 2015 according to SRatingsIntel. As per Thursday, November 16, the company rating was maintained by Jefferies. The stock of Viacom, Inc. (NASDAQ:VIAB) earned “Hold” rating by Zacks on Tuesday, August 11. On Thursday, July 13 the stock rating was maintained by BMO Capital Markets with “Hold”. The firm has “Neutral” rating by Atlantic Securities given on Wednesday, February 14. On Thursday, January 4 the stock rating was maintained by Wells Fargo with “Hold”. The company was maintained on Friday, August 7 by Topeka Capital Markets. The stock of Viacom, Inc. (NASDAQ:VIAB) has “Buy” rating given on Monday, January 9 by Guggenheim. The rating was maintained by UBS with “Buy” on Friday, November 17. Cowen & Co maintained the shares of VIAB in report on Friday, November 17 with “Hold” rating. Piper Jaffray maintained Viacom, Inc. (NASDAQ:VIAB) rating on Sunday, September 24. Piper Jaffray has “Hold” rating and $40.0 target.

Since February 9, 2018, it had 0 insider purchases, and 3 selling transactions for $1.71 million activity.

Southpoint Capital Advisors Lp, which manages about $2.99 billion and $2.10B US Long portfolio, decreased its stake in Etsy Inc by 850,000 shares to 750,000 shares, valued at $15.34M in 2017Q4, according to the filing. It also reduced its holding in Comcast Corp New (NASDAQ:CMCSA) by 500,000 shares in the quarter, leaving it with 3.50M shares, and cut its stake in Cognizant Technology Solutio (NASDAQ:CTSH).

Investors sentiment is 1.17 in Q4 2017. Its the same as in 2017Q3. It is flat, as 62 investors sold REGN shares while 161 reduced holdings. only 71 funds opened positions while 191 raised stakes. 69.17 million shares or 6.15% less from 73.70 million shares in 2017Q3 were reported. Advisor Prtn Llc stated it has 1,588 shares or 0.11% of all its holdings. Norinchukin Natl Bank The invested in 0.04% or 6,160 shares. Nippon Life Americas accumulated 36,540 shares. Bank & Trust Of America Corporation De has 948,255 shares for 0.06% of their portfolio. Tudor Corporation Et Al reported 0.04% stake. Moreover, Lazard Asset Mgmt Limited Company has 0% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for 4 shares. 100 are owned by Adirondack. Avalon Limited Liability Co owns 0.23% invested in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for 19,860 shares. Natl Pension Ser invested 0.14% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Solaris Asset Mngmt stated it has 0.03% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Panagora Asset Management stated it has 0.08% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Los Angeles Management & Equity Inc holds 91,142 shares or 0.19% of its portfolio. Loring Wolcott & Coolidge Fiduciary Advsr Ltd Liability Partnership Ma invested in 0.01% or 745 shares. Retirement Sys Of Alabama has 37,332 shares for 0.07% of their portfolio. Raymond James Na holds 0.02% of its portfolio in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for 779 shares.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: